Skip to main content

Table 1 Demographics and concomitant medication

From: Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

  Overall 40 ml EcN 20 ml EcN 10 ml EcN Placebo
Age (years) 41.8 ± 12.7 40.5 ± 14.3 42.3 ± 12.0 37.5 ± 9.0 47.4 ± 13.8
Gender (m : f) 49 : 39 13 : 10 13 : 10 11 : 11 12 : 8
Smoking 3/88 2/23 1/23 0/22 0/20
Previous colonic surgery - - 2/23 - 1/20
Antidiarrhoeal, antiinflammatory and/or antiinfective medication 53/88
60.2%
15/23
65.2%
11/23
47.8%
15/22
68.2%
12/20
60.0%
Systemic corticosteroids 14/88
15.9%
3/23
13.0%
3/23
13.0%
6/22
27.3%
2/20
10.0%
\